Momenta Pharma (MNTA)
$52.48
0.00 (0.00%)
19:41 EDT
MNTA Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
4.07B
PE Ratio
-38.31
EPS
-1.37
Volume (Avg. Vol.)
Day's Range
52.48 - 52.48
52-Week Range
20.53 - 52.50
Dividend & Yield
N/A (N/A)
MNTA Stock Predictions, Articles, and Momenta Pharma News
- From InvestorPlace
- From the Web
Buyout Excitement Is Already Priced Into Momenta Pharmaceuticals
Momenta Pharmaceuticals stock was thrust into the financial headlines and might look tempting, but don't forget that price is king.
Momenta Pharmaceuticals News: MNTA Stock Rockets 69% on JNJ Deal
Momenta Pharmaceuticals (MNTA) news for Wednesday includes a deal with Johnson & Johnson (JNJ) sending MNTA stock rocketing higher.
Mylan Stock is One Stumble Away From a Big Technical Pullback
Thinking about buying Mylan stock? You may not want to just yet. It's toying with a support line that, if it snaps, could open the selling floodgates.
How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover
Teva Pharmaceutical desperately needs a new CEO - and a new strategy to boot - to stop the steady decline in TEVA stock.
No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn’t Doomed
Teva Pharmaceutical (TEVA) has more upside than most investors realize. Look past the Copaxone debacle, and TEVA stock is promising.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Fading Fast
Despite Teva's (TEVA) gains on earnings and rival delays, TEVA stock is still facing impassive sentiment and broad selling pressure.
5 Stocks to Buy as Trump Chalks Out ‘Phenomenal’ Tax Plan
Small caps are well positioned to benefit from a reduction in tax rates. Consider these 5 stocks to buy on a tax rate reduction
